These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 33515283
1. Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine. Lim HX, Lim J, Poh CL. Med Microbiol Immunol; 2021 Feb; 210(1):1-11. PubMed ID: 33515283 [Abstract] [Full Text] [Related]
4. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species. Grifoni A, Voic H, Dhanda SK, Kidd CK, Brien JD, Buus S, Stryhn A, Durbin AP, Whitehead S, Diehl SA, De Silva AD, Balmaseda A, Harris E, Weiskopf D, Sette A. J Virol; 2020 May 04; 94(10):. PubMed ID: 32132233 [Abstract] [Full Text] [Related]
8. Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines. Pinheiro JR, Camilo Dos Reis E, Souza RDSO, Rocha ALS, Suesdek L, Azevedo V, Tiwari S, Rocha BGS, Birbrair A, Méndez EC, Luiz WB, Amorim JH. Front Immunol; 2021 May 04; 12():715136. PubMed ID: 34489965 [Abstract] [Full Text] [Related]
12. Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins. Nadugala MN, Jeewandara C, Jadi RS, Malavige GN, de Silva AM, Premaratne PH, Goonasekara CL. BMC Immunol; 2021 Nov 03; 22(1):71. PubMed ID: 34732126 [Abstract] [Full Text] [Related]
13. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. Weiskopf D, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, de Silva AD, Lindow JC, Diehl SA, Whitehead S, Durbin A, Kirkpatrick B, Sette A. J Virol; 2015 Jan 03; 89(1):120-8. PubMed ID: 25320311 [Abstract] [Full Text] [Related]
15. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A. J Virol; 2014 Oct 03; 88(19):11383-94. PubMed ID: 25056881 [Abstract] [Full Text] [Related]
17. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes. Andrade DV, Katzelnick LC, Widman DG, Balmaseda A, de Silva AM, Baric RS, Harris E. mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928210 [Abstract] [Full Text] [Related]
19. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus. Fadaka AO, Sibuyi NRS, Martin DR, Goboza M, Klein A, Madiehe AM, Meyer M. Sci Rep; 2021 Oct 05; 11(1):19707. PubMed ID: 34611250 [Abstract] [Full Text] [Related]